CUV 2.17% $14.40 clinuvel pharmaceuticals limited

Ann: Clinuvel commences US Phase III trial of SCE, page-8

  1. 2,941 Posts.
    re: Ann: Clinuvel commences US Phase III tria... With your knowledge, I feel this product has shown that it safe and appears to be looking good for approval.
    Would you agree, or is it still a big possibility that they decline it?
 
watchlist Created with Sketch. Add CUV (ASX) to my watchlist
(20min delay)
Last
$14.40
Change
-0.320(2.17%)
Mkt cap ! $728.6M
Open High Low Value Volume
$15.00 $15.00 $14.40 $417.7K 28.69K

Buyers (Bids)

No. Vol. Price($)
14 5476 $14.40
 

Sellers (Offers)

Price($) Vol. No.
$14.42 75 9
View Market Depth
Last trade - 13.32pm 09/09/2024 (20 minute delay) ?
CUV (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.